News
Guggenheim Reiterates Buy on Immunocore Hldgs, Maintains $92 Price Target
23 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Immunocore Hldgs Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
11 Apr 24
Analyst Ratings
Needham Reiterates Buy on Immunocore Hldgs, Maintains $81 Price Target
11 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Immunocore Says Selling Shareholders May Offer & Resell Up To 1.2M ADS, Pursuant To Prospectus Supplement
5 Apr 24
News, Offerings
JP Morgan Maintains Overweight on Immunocore Hldgs, Raises Price Target to $70
21 Mar 24
News, Price Target, Analyst Ratings
Mizuho Maintains Buy on Immunocore Hldgs, Raises Price Target to $90
5 Mar 24
News, Price Target, Analyst Ratings
Key Takeaways From Immunocore Hldgs Analyst Ratings
29 Feb 24
Analyst Ratings
Oppenheimer Reiterates Outperform on Immunocore Hldgs, Raises Price Target to $87
29 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Canaccord Genuity Maintains Hold on Immunocore Hldgs, Raises Price Target to $63
29 Feb 24
News, Price Target, Analyst Ratings
Needham Reiterates Buy on Immunocore Hldgs, Maintains $81 Price Target
29 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Immunocore Hldgs Q4 GAAP EPS $(0.40) Misses $(0.28) Estimate, Sales $67.59M Beat $67.23M Estimate
28 Feb 24
Earnings, News
Earnings Scheduled For February 28, 2024
28 Feb 24
Earnings
Immunocore Hldgs's Earnings: A Preview
27 Feb 24
Earnings
Immunocore Inks Clinical Trial Collaboration And Supply Agreement With Bristol Myers Squibb; No Financial Terms Disclosed
22 Feb 24
News, Contracts
Mizuho Maintains Buy on Immunocore Hldgs, Raises Price Target to $86
16 Feb 24
News, Price Target, Analyst Ratings
Immunocore Prices Upsized $350M 2.50% Convertible Senior Notes Due 2030
31 Jan 24
News
Press releases
Immunocore to present at upcoming investor conferences
4 Apr 24
News, Press Releases
Immunocore presented two posters at CROI 2024
5 Mar 24
Press Releases
Immunocore to present at upcoming investor conferences
1 Mar 24
News, Press Releases
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
28 Feb 24
Earnings, Press Releases
Immunocore Prices Upsized Convertible Senior Notes Offering
30 Jan 24
Press Releases
Immunocore Announces Proposed Convertible Senior Notes Offering
29 Jan 24
Press Releases